These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection. Cagigi A; Mowafi F; Phuong Dang LV; Tenner-Racz K; Atlas A; Grutzmeier S; Racz P; Chiodi F; Nilsson A Blood; 2008 Dec; 112(12):4401-10. PubMed ID: 18780835 [TBL] [Abstract][Full Text] [Related]
10. CXC chemokine ligand-13 promotes metastasis via CXCR5-dependent signaling pathway in non-small cell lung cancer. Chao CC; Lee WF; Wang SW; Chen PC; Yamamoto A; Chang TM; Weng SL; Liu JF J Cell Mol Med; 2021 Oct; 25(19):9128-9140. PubMed ID: 34427969 [TBL] [Abstract][Full Text] [Related]
11. Cofilin-mediated F-actin severing is regulated by the Rap GTPase and controls the cytoskeletal dynamics that drive lymphocyte spreading and BCR microcluster formation. Freeman SA; Lei V; Dang-Lawson M; Mizuno K; Roskelley CD; Gold MR J Immunol; 2011 Dec; 187(11):5887-900. PubMed ID: 22068232 [TBL] [Abstract][Full Text] [Related]
12. CXCR5 is critically involved in progression of lupus through regulation of B cell and double-negative T cell trafficking. Wiener A; Schippers A; Wagner N; Tacke F; Ostendorf T; Honke N; Tenbrock K; Ohl K Clin Exp Immunol; 2016 Jul; 185(1):22-32. PubMed ID: 26990531 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Bürkle A; Niedermeier M; Schmitt-Gräff A; Wierda WG; Keating MJ; Burger JA Blood; 2007 Nov; 110(9):3316-25. PubMed ID: 17652619 [TBL] [Abstract][Full Text] [Related]
15. Actin-binding protein 1 regulates B cell receptor-mediated antigen processing and presentation in response to B cell receptor activation. Onabajo OO; Seeley MK; Kale A; Qualmann B; Kessels M; Han J; Tan TH; Song W J Immunol; 2008 May; 180(10):6685-95. PubMed ID: 18453588 [TBL] [Abstract][Full Text] [Related]
16. CXCL13 antibody for the treatment of autoimmune disorders. Klimatcheva E; Pandina T; Reilly C; Torno S; Bussler H; Scrivens M; Jonason A; Mallow C; Doherty M; Paris M; Smith ES; Zauderer M BMC Immunol; 2015 Feb; 16(1):6. PubMed ID: 25879435 [TBL] [Abstract][Full Text] [Related]
17. The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation. Vascotto F; Lankar D; Faure-André G; Vargas P; Diaz J; Le Roux D; Yuseff MI; Sibarita JB; Boes M; Raposo G; Mougneau E; Glaichenhaus N; Bonnerot C; Manoury B; Lennon-Duménil AM J Cell Biol; 2007 Mar; 176(7):1007-19. PubMed ID: 17389233 [TBL] [Abstract][Full Text] [Related]
18. CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5. Jiang BC; Cao DL; Zhang X; Zhang ZJ; He LN; Li CH; Zhang WW; Wu XB; Berta T; Ji RR; Gao YJ J Clin Invest; 2016 Feb; 126(2):745-61. PubMed ID: 26752644 [TBL] [Abstract][Full Text] [Related]
19. CD23 can negatively regulate B-cell receptor signaling. Liu C; Richard K; Wiggins M; Zhu X; Conrad DH; Song W Sci Rep; 2016 May; 6():25629. PubMed ID: 27181049 [TBL] [Abstract][Full Text] [Related]
20. CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis. Trolese MC; Mariani A; Terao M; de Paola M; Fabbrizio P; Sironi F; Kurosaki M; Bonanno S; Marcuzzo S; Bernasconi P; Trojsi F; Aronica E; Bendotti C; Nardo G EBioMedicine; 2020 Dec; 62():103097. PubMed ID: 33161233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]